BrainsWay Ltd. (BWAY)
USD 9.08
(-4.32%)
USD 9.08
(-4.32%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 28.01 Million USD | -14.4% |
| 2022 | 32.73 Million USD | 16.66% |
| 2021 | 28.05 Million USD | 28.54% |
| 2020 | 21.82 Million USD | -17.47% |
| 2019 | 26.44 Million USD | 47.57% |
| 2018 | 17.92 Million USD | 18.21% |
| 2017 | 15.16 Million USD | 35.78% |
| 2016 | 11.16 Million USD | 13.49% |
| 2015 | 9.83 Million USD | -1.62% |
| 2014 | 10 Million USD | 90.24% |
| 2013 | 5.25 Million USD | -11.59% |
| 2012 | 5.94 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 6.95 Million USD | 3.45% |
| 2024 Q1 | 6.71 Million USD | 2.5% |
| 2023 FY | 28.01 Million USD | -14.4% |
| 2023 Q2 | 7.07 Million USD | -16.74% |
| 2023 Q1 | 8.5 Million USD | -1.47% |
| 2023 Q4 | 6.55 Million USD | 3.98% |
| 2023 Q3 | 6.3 Million USD | -10.92% |
| 2022 Q1 | 7.58 Million USD | -5.38% |
| 2022 FY | 32.73 Million USD | 16.66% |
| 2022 Q4 | 8.62 Million USD | -0.8% |
| 2022 Q3 | 8.69 Million USD | 11.19% |
| 2022 Q2 | 7.82 Million USD | 3.12% |
| 2021 Q3 | 7.36 Million USD | 2.02% |
| 2021 Q1 | 6.76 Million USD | 14.47% |
| 2021 FY | 28.05 Million USD | 28.54% |
| 2021 Q2 | 7.21 Million USD | 6.74% |
| 2021 Q4 | 8.01 Million USD | 8.85% |
| 2020 Q2 | 4.04 Million USD | -40.22% |
| 2020 Q4 | 5.9 Million USD | 15.48% |
| 2020 FY | 21.82 Million USD | -17.47% |
| 2020 Q1 | 6.76 Million USD | -1.14% |
| 2020 Q3 | 5.11 Million USD | 26.51% |
| 2019 Q4 | 6.84 Million USD | -1.62% |
| 2019 Q2 | 7.02 Million USD | 24.62% |
| 2019 FY | 26.44 Million USD | 47.57% |
| 2019 Q1 | 5.63 Million USD | 3.95% |
| 2019 Q3 | 6.95 Million USD | -0.94% |
| 2018 Q4 | 5.41 Million USD | 25.73% |
| 2018 Q3 | 4.31 Million USD | 11.43% |
| 2018 FY | 17.92 Million USD | 18.21% |
| 2018 Q2 | 3.86 Million USD | -10.57% |
| 2018 Q1 | 4.32 Million USD | -9.25% |
| 2017 Q2 | 3.61 Million USD | 13.45% |
| 2017 Q4 | 4.76 Million USD | 32.35% |
| 2017 Q3 | 3.6 Million USD | -0.28% |
| 2017 Q1 | 3.18 Million USD | -9.16% |
| 2017 FY | 15.16 Million USD | 35.78% |
| 2016 Q1 | 3.18 Million USD | -11.67% |
| 2016 FY | 11.16 Million USD | 13.49% |
| 2016 Q4 | 3.5 Million USD | 6.57% |
| 2016 Q3 | 3.28 Million USD | 177.0% |
| 2016 Q2 | 1.18 Million USD | -62.75% |
| 2015 FY | 9.83 Million USD | -1.62% |
| 2015 Q4 | 3.6 Million USD | 84.93% |
| 2015 Q3 | 1.95 Million USD | -5.76% |
| 2015 Q1 | 8.99 Million USD | 179.0% |
| 2015 Q2 | 2.07 Million USD | -76.97% |
| 2014 Q4 | 3.22 Million USD | 0.4% |
| 2014 FY | 10 Million USD | 90.24% |
| 2014 Q1 | 6.49 Million USD | 35.6% |
| 2014 Q3 | 3.2 Million USD | 65.44% |
| 2014 Q2 | 1.94 Million USD | -70.12% |
| 2013 Q3 | 1.45 Million USD | 97.08% |
| 2013 Q4 | 4.78 Million USD | 230.07% |
| 2013 FY | 5.25 Million USD | -11.59% |
| 2013 Q1 | 5.19 Million USD | 214.67% |
| 2013 Q2 | 735.98 Thousand USD | -85.82% |
| 2012 Q3 | 1.61 Million USD | 0.0% |
| 2012 FY | 5.94 Million USD | 0.0% |
| 2012 Q4 | 1.64 Million USD | 1.86% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -149.626% |
| Cerus Corporation | 143.15 Million USD | 80.428% |
| OrthoPediatrics Corp. | 137.01 Million USD | 79.552% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -146.619% |
| Talis Biomedical Corporation | 67.18 Million USD | 58.298% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -12.315% |
| Inogen, Inc. | 236.08 Million USD | 88.132% |
| Spectral AI, Inc. | 20.86 Million USD | -34.289% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 49.965% |
| CVRx, Inc. | 76.14 Million USD | 63.203% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -694.162% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -124.341% |
| Orthofix Medical Inc. | 667.42 Million USD | 95.802% |
| Venus Concept Inc. | 80.47 Million USD | 65.185% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 50.479% |
| Bioventus Inc. | 409.91 Million USD | 93.165% |
| Envoy Medical, Inc. | 17.89 Million USD | -56.543% |
| electroCore, Inc. | 32.03 Million USD | 12.528% |
| IceCure Medical Ltd | 16.87 Million USD | -66.023% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 33.97% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -58.895% |
| MaxCyte, Inc. | 84.84 Million USD | 66.977% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -125.737% |
| Nexalin Technology, Inc. | 5.78 Million USD | -384.627% |
| PAVmed Inc | 64.82 Million USD | 56.78% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 45.147% |
| RxSight, Inc. | 103.85 Million USD | 73.021% |
| Sight Sciences, Inc. | 126.44 Million USD | 77.842% |
| SI-BONE, Inc. | 156.35 Million USD | 82.08% |
| TELA Bio, Inc. | 84.18 Million USD | 66.719% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 60.006% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 86.223% |
| LivaNova PLC | 843.54 Million USD | 96.679% |
| 908 Devices Inc. | 68.08 Million USD | 58.845% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 94.206% |
| Nemaura Medical Inc. | 7.13 Million USD | -292.475% |
| NeuroPace, Inc. | 75.29 Million USD | 62.79% |
| LENSAR, Inc. | 33.33 Million USD | 15.953% |
| Apyx Medical Corporation | 51.01 Million USD | 45.082% |
| Cutera, Inc. | 197.72 Million USD | 85.83% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -13.062% |
| BioSig Technologies, Inc. | 28.53 Million USD | 1.795% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 85.367% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 22.302% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 96.65% |
| Axonics, Inc. | 270.2 Million USD | 89.631% |
| Outset Medical, Inc. | 198.77 Million USD | 85.904% |
| IRIDEX Corporation | 31.81 Million USD | 11.932% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 84.453% |
| IRadimed Corporation | 30.12 Million USD | 6.987% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -228.387% |
| INVO Bioscience, Inc. | 7.85 Million USD | -256.768% |
| Telesis Bio, Inc. | 63.48 Million USD | 55.87% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 71.542% |
| Varex Imaging Corporation | 224.8 Million USD | 87.536% |
| Quipt Home Medical Corp. | 148.66 Million USD | 81.154% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -139.0% |
| Pulmonx Corporation | 112.68 Million USD | 75.136% |
| Dynatronics Corporation | 9.9 Million USD | -182.781% |
| Modular Medical, Inc. | 17.52 Million USD | -59.838% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -38.792% |
| Semler Scientific, Inc. | 38.94 Million USD | 28.056% |
| InMode Ltd. | 215.68 Million USD | 87.009% |
| Bruker Corporation | 1.07 Billion USD | 97.397% |
| Cytosorbents Corporation | 48.33 Million USD | 42.036% |
| DexCom, Inc. | 1.69 Billion USD | 98.343% |
| Align Technology, Inc. | 2.07 Billion USD | 98.651% |
| Viveve Medical, Inc. | 22.17 Million USD | -26.361% |
| ZimVie Inc. | 275.12 Million USD | 89.816% |
| Movano Inc. | 29.69 Million USD | 5.632% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 79.589% |
| Nexalin Technology, Inc. | 5.78 Million USD | -384.627% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -694.162% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 95.337% |
| Profound Medical Corp. | 33.6 Million USD | 16.621% |
| Insulet Corporation | 939.9 Million USD | 97.019% |
| enVVeno Medical Corporation | 25.23 Million USD | -11.015% |
| Surmodics, Inc. | 98.69 Million USD | 71.612% |
| iCAD, Inc. | 22.22 Million USD | -26.065% |
| Nuwellis, Inc. | 22.61 Million USD | -23.902% |
| Biotricity, Inc. | 17.18 Million USD | -63.042% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 93.716% |
| Aethlon Medical, Inc. | 12.27 Million USD | -128.206% |
| InspireMD, Inc. | 22.95 Million USD | -22.083% |
| PAVmed Inc. | 64.82 Million USD | 56.78% |
| BIOLASE, Inc. | 34.66 Million USD | 19.166% |
| Beyond Air, Inc. | 61.7 Million USD | 54.59% |
| FONAR Corporation | 28.6 Million USD | 2.051% |
| AxoGen, Inc. | 149.33 Million USD | 81.238% |
| Vivani Medical, Inc. | 26.96 Million USD | -3.905% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 84.179% |
| Inari Medical, Inc. | 448.59 Million USD | 93.754% |
| UFP Technologies, Inc. | 58.08 Million USD | 51.767% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -468.593% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -343.443% |
| Tenon Medical, Inc. | 16.96 Million USD | -65.123% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -278.98% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 36.471% |
| AdaptHealth Corp. | 1.07 Billion USD | 97.401% |
| Sintx Technologies, Inc. | 15.2 Million USD | -84.317% |
| NanoVibronix, Inc. | 4.97 Million USD | -463.402% |
| Quanterix Corporation | 118.1 Million USD | 76.276% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -139.0% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -94.004% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 92.865% |
| TransMedics Group, Inc. | 182.82 Million USD | 84.675% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 0.167% |
| NeuroMetrix, Inc. | 11.09 Million USD | -152.439% |
| Hyperfine, Inc. | 52.87 Million USD | 47.008% |
| Establishment Labs Holdings Inc. | 172 Million USD | 83.711% |
| Biomerica, Inc. | 6.97 Million USD | -301.519% |
| Bone Biologics Corporation | 9.42 Million USD | -197.169% |
| AVITA Medical, Inc. | 80.77 Million USD | 65.315% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -171.724% |
| Silk Road Medical, Inc | 186.35 Million USD | 84.965% |